Blood Transfusion and Intravenous Equipment Market Global Report 2022-2026

Focus on Main Patent Trends within the Industry and Market Player Profiles

“Global Blood Transfusion and Intravenous Equipment Market” report has been added to ResearchAndMarkets.com’s offering.

The scope of this report is broad. It covers blood transfusion products, blood intravenous products and end users of blood transfusion and intravenous equipment.

The market has been segmented by transfusion products into apheresis devices, blood bags and accessories, blood component separators, blood mixers, consumables and supplies, filters, fridges and freezers, and pathogen reduction systems. Revenue forecasts for 2021-2026 are given for each segment and regional market with estimated values derived from the revenue of manufacturers’ total revenues. The main geographic markets, including North America, Europe, Asia-Pacific and the Rest of the World (ROW), are included.

The report also includes a discussion of the major players across each region in the blood transfusion and intravenous equipment market. Further, it explains the major drivers and regional dynamics of the global blood transfusion and intravenous equipment market and current trends within the industry.

Key industry acquisitions and strategic alliances are given from 2015 to 2020.

This report also examines the main patent trends within the industry and profiles market players that deal in blood transfusion and intravenous equipment.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the main vendors in the global blood transfusion and intravenous equipment market.

Report Includes

An up-to-date review of the global blood transfusion and intravenous (IV) equipment market
Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, and projections of compound annual growth rates (CAGRs) through 2026
Highlights of the upcoming market potential for blood transfusion and intravenous equipment, and areas of focus to forecast this market into various segments and sub-segments
Evaluation and forecast the global market size for blood transfusion and IV equipment revenues, projected growth trends, and corresponding market share analysis by product type, end user, and geographic region
Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2021 to 2027)
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
In-depth information on R&D investment, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market

The blood transfusion market is expected to see significant gains over the next few years on account of numerous technological advancements in this field. One of the key advancements includes the use of stem cell technology for the development of lab-grown blood cells of blood groups for human use. This is expected to have a positive impact on the industry over the forecast period.

The market is segmented into two parts: blood transfusion market and the intravenous equipment market.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Introduction
Market Potential
Regulatory Framework
The National Center for Biotechnology Information
Joint U.K. Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee
World Health Organization (Who)
National Aids Control Organization
Food and Drug Administration (Fda)
Recommendations for Investigational Covid-19 Convalescent Plasma
Porter’s Five Forces Analysis
Threat of New Entrants
Bargaining Power of Buyers
Competitive Rivalry
Threat of Substitutes
Bargaining Power of Suppliers
Growth Indicators
Technological Trends
Regulatory Trends
Industry Growth Drivers
Rising Prevalence of Chronic Diseases
Increasing Number of Surgical Procedures
Increasing Road Accidents
Growing Geriatric Populations
Growth in Home Care Driving Demand for Ambulatory Infusion Pumps

Chapter 4 Impact of the Covid-19 Pandemic

Overview
Impact on Medtech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Impact of Covid-19 on the Blood Transfusion Services Market
Impact of Covid-19 on the Intravenous Equipment Market

Chapter 5 Blood Transfusion Market by Product Type

Apheresis Devices
Blood Bags and Accessories
Blood Component Separators
Blood Mixers
Consumables and Supplies
Filters
Fridges and Freezers
Pathogen Reduction Systems
Others

Chapter 6 Intravenous Equipment Market by Product Type

Administration Sets
Drip Chambers
Infusion Pumps
Iv Catheters
Needleless Connectors
Securement Devices
Stopcocks and Check Valves
Others

Chapter 7 Blood Transfusion and Intravenous Equipment Market by End-user

Ambulatory Surgical Centers
Hospitals
Others

Chapter 8 Blood Transfusion and Intravenous Equipment Market by Region

North America
Europe
Asia-Pacific
Rest of the World

Chapter 9 Competitive Landscape

Mergers and Acquisitions
Amsino International
Angiodynamics
Argon Medical Devices
B. Braun Melsungen AG
Baxter International, Inc.
Becton Dickinson and Co.
Cardinal Health
Fresenius Se & Co. Kgaa
Icu Medical, Inc.
Innovations
Vendor Landscape

Chapter 10 Company Profiles

Amsino International Inc.
Angiodynamics Inc.
Argon Medical Devices Inc.
B. Braun Melsungen AG
Baxter International Inc.
BD
Cardinal Health, Inc.
Codan Us Corp.
Elcam Medical Inc.
Fresenius Se & Co. Kgaa
Grifols S.A.
Haemonetics Corp.
Halyard Health Inc.
Icu Medical, Inc.
Immucor Inc.
Iradimed Corp.
Macopharma Sa
Medline Industries
Moog Inc.
Poly Medicure Ltd.
Zyno Medical LLC

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”